Close Menu
Invest Insider News
    Facebook X (Twitter) Instagram
    Saturday, November 21
    Facebook X (Twitter) Instagram Pinterest Vimeo
    Invest Insider News
    • Home
    • Bitcoin
    • Commodities
    • Finance
    • Investing
    • Property
    • Stock Market
    • Utilities
    Invest Insider News
    Home»Investing»AstraZeneca stock dips as HSBC downgrades stock on ’tough path ahead’ By Investing.com
    Investing

    AstraZeneca stock dips as HSBC downgrades stock on ’tough path ahead’ By Investing.com

    July 13, 20262 Mins Read


    Investing.com — HSBC has downgraded AstraZeneca () () to Hold from Buy and slashed its price target to 13,750 pence from 16,500 pence, after the drugmaker’s Wainua trial failed to meet its primary endpoint in a Phase 3 study.

    “Wainua setback impairs our bull case, given the more difficult catalyst path ahead,” HSBC analyst Rajesh Kumar said in a note.

    Shares in the British pharma giant fell 1.3% in London trading, while its U.S.-listed shares shed 1.5% in the premarket trade.

    Success in the CARDIO-TTR trial had underpinned HSBC’s positive view on the stock, Kumar noted, representing a market opportunity of more than $5 billion.

    The analyst cited three reasons for losing conviction in his bullish case. First, while the path to more than $80 billion in peak revenues by 2030 still exists, it now depends on catalysts that are more volatile and unlikely to read out before 2027.

    Second, HSBC’s own trial analysis left it “rather uncomfortable” with upcoming SERENA-4 and AVANZAR readouts expected in the second half of 2026.

    Finally, Kumar warned that “if three trials fail in a sequence, the widely held view of Astra’s market-leading R&D platform might lose its shine,” potentially capping the stock’s ability to re-rate.

    HSBC’s scenario analysis suggests that if the bear cases for SERENA-4 and AVANZAR play out, concerns about AstraZeneca’s ability to manage revenue decline amid large patent cliffs in the early 2030s would leave the company’s upside “capped on a 6-9-month basis,” reliant on catalyst successes in 2027.

    “We downgrade the stock to a Hold rating (from Buy) as we no longer find the risk-reward balance attractive, particularly with the remaining catalyst path for 2026 (SERENA‑4, AVANZAR) skewed to downside risks,” Kumar concluded.





    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleCommodities: Forward curves and carry framework – Societe Generale
    Next Article Can this chip sector work if memory doesn’t? By Investing.com

    Related Posts

    Investing

    NZD/INR Historical Data | New Zealand Dollar Indian Rupee

    October 30, 2026
    Investing

    GBP 2 Years IRS Interest Rate Swap Bond Chart (Live Data)

    October 27, 2026
    Investing

    USD/CNY Historical Data | US Dollar Chinese Yuan

    October 25, 2026
    Leave A Reply Cancel Reply

    Top Posts

    How is the UK Commercial Property Market Performing?

    December 31, 2000

    How much are they in different states across the US?

    December 31, 2000

    A Guide To Becoming A Property Developer

    December 31, 2000
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews
    Bitcoin

    Bitcoin Worth $15 Billion Seized in DOJ Action Against ‘Fraud Empire’

    October 14, 2025
    Bitcoin

    Bitcoin Price Soars Above $120K As Nakamoto Prepares $760 Million BTC Buy Post-Merger

    August 11, 2025
    Bitcoin

    Les principales cryptomonnaies affichent des résultats mitigés ; le Bitcoin se maintient au-dessus de 95 000 dollars

    April 25, 2025
    What's Hot

    Le Bitcoin prêt à augmenter alors que le yuan de la Chine atteint son niveau le plus bas en 2023

    April 8, 2025

    TON Foundation announces trustless Bitcoin bridge

    July 17, 2024

    BTC News: Bitcoin May Soar to $500K in 2026 Says Arthur Hayes on Fed Outlook

    November 29, 2025
    Most Popular

    Why Bitcoin, Ethereum, XRP struggle to sustain recovery?

    November 28, 2025

    Stock market today: Dow slips, S&P and Nasdaq gain as chip stocks rally, focus shifts to midterm elections

    November 3, 2026

    3 Mining Stocks to Ride the Commodity Boom Into 2026

    December 10, 2025
    Editor's Picks

    China Government Vows New Measures To Support Property Sector

    October 13, 2024

    US stocks mixed; Netflix surges as earnings season continues By Investing.com

    October 18, 2024

    Latest filings in campaign finance court battle argue Maine has legal right to regulate super PACs

    October 22, 2025
    Facebook X (Twitter) Instagram Pinterest Vimeo
    • Get In Touch
    • Privacy Policy
    • Terms and Conditions
    © 2026 Invest Insider News

    Type above and press Enter to search. Press Esc to cancel.